ALUMIS INC Share Price Today: Live Updates & Key Insights

ALUMIS INC share price today is $25.19, up -1.26%. The stock opened at $24.97 against the previous close of $25.38, with an intraday high of $25.22 and low of $24.1.

ALUMIS INC Share Price Chart

ALUMIS INC

us-stock
To Invest in {{usstockname}}
us-stock

ALUMIS INC Share Price Performance

$25.19 -0.0126(-1.26%) ALMS at 23 Mar 2026 11:58 AM Biotechnology
Lowest Today 24.1
Highest Today 25.22
Today’s Open 24.97
Prev. Close 25.38
52 Week High 30.60
52 Week Low 2.76
Day’s Range: Low 24.1 High 25.22
52-Week Range: Low 2.76 High 30.60
1 day return -
1 Week return -4.2
1 month return -9.36
3 month return +123.94
6 month return +504.58
1 year return +554.3
3 year return -
5 year return -
10 year return -

ALUMIS INC Institutional Holdings

ALUMIS INC Market Status

Strong Buy: 4

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

ALUMIS INC Fundamentals

Market Cap 3171.76 M

PB Ratio 8.2247

PE Ratio 0.0

Enterprise Value 2824.73 M

Total Assets 411.94 M

Volume 4029994

ALUMIS INC Company Financials

Annual Revenue FY23:0 0.0M

Annual Profit FY23:null 0.0M

Annual Net worth FY23:-154993000 -155.0M

Quarterly Revenue Q3/2025:2066000 2.1M, Q2/2025:2666000 2.7M, Q1/2025:17389000 17.4M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:2066000 2.1M, Q2/2025:2666000 2.7M, Q1/2025:17389000 17.4M, Q3/2024:null 0.0M, Q2/2024:-760000 -0.8M

Quarterly Net worth Q3/2025:-110752000 -110.8M, Q2/2025:59321000 59.3M, Q1/2025:-98963000 -99.0M, Q3/2024:-93117000 -93.1M, Q2/2024:-56508000 -56.5M

About ALUMIS INC & investment objective

Company Information Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. The company offers envudeucitinib, a tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis and systemic lupus erythematosus; and A-005, a central nervous system-penetrant allosteric TYK2 inhibitor that is in Phase 1 for the treatment of neuroinflammatory and neurodegenerative diseases. It also develops lonigutamab, a monoclonal antibody targeting IGF-1R for the treatment of thyroid eye diseases; and interferon regulatory factor 5 (IRF5) to address immune dysfunction. The company was formerly known as Esker Therapeutics, Inc. and changed its name to Alumis Inc. in January 2022. Alumis Inc. was incorporated in 2021 and is headquartered in South San Francisco, California.

Organisation Biotechnology

Employees 221

Industry Biotechnology

CEO Mr. Martin Babler Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

ALUMIS INC FAQs

What is the share price of ALUMIS INC today?

The current share price of ALUMIS INC is $25.19.

Can I buy ALUMIS INC shares in India?

Yes, Indian investors can buy ALUMIS INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy ALUMIS INC shares in India?

You can easily invest in ALUMIS INC shares from India by:

Can I buy fractional shares of ALUMIS INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of ALUMIS INC?

ALUMIS INC has a market cap of $3171.76 M.

In which sector does ALUMIS INC belong?

ALUMIS INC operates in the Biotechnology sector.

What documents are required to invest in ALUMIS INC stocks?

To invest, you typically need:

What is the PE and PB ratio of ALUMIS INC?

The PE ratio of ALUMIS INC is N/A and the PB ratio is 8.22.